Menu
GeneBe

PODXL

podocalyxin like

Basic information

Region (hg38): 7:131500261-131558217

Links

ENSG00000128567NCBI:5420OMIM:602632HGNC:9171Uniprot:O00592AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • young-onset Parkinson disease (Supportive), mode of inheritance: AR
  • atypical juvenile parkinsonism (Supportive), mode of inheritance: AR

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PODXL gene.

  • not provided (152 variants)
  • Inborn genetic diseases (25 variants)
  • Parkinson disease, late-onset (3 variants)
  • Autosomal recessive juvenile Parkinson disease 2 (1 variants)
  • not specified (1 variants)
  • PODXL-related condition (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PODXL gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
26
clinvar
16
clinvar
45
missense
53
clinvar
14
clinvar
9
clinvar
76
nonsense
2
clinvar
2
start loss
0
frameshift
1
clinvar
1
clinvar
2
clinvar
4
inframe indel
5
clinvar
1
clinvar
3
clinvar
9
splice donor/acceptor (+/-2bp)
0
splice region
1
3
2
6
non coding
5
clinvar
20
clinvar
25
Total 2 1 62 46 50

Variants in PODXL

This is a list of pathogenic ClinVar variants found in the PODXL region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-131504303-A-C PODXL-related disorder Likely benign (Dec 13, 2022)3033655
7-131504305-A-C PODXL-related disorder Likely benign (Dec 13, 2022)3034356
7-131504335-A-G Benign (Mar 20, 2022)1555206
7-131504336-T-C Inborn genetic diseases Uncertain significance (Jul 25, 2023)2568607
7-131504346-C-T Inborn genetic diseases Conflicting classifications of pathogenicity (Aug 16, 2021)1457388
7-131504348-T-C Likely benign (May 01, 2023)2049227
7-131504351-G-A Inborn genetic diseases Uncertain significance (Apr 08, 2022)2282586
7-131504353-C-T Likely benign (Oct 27, 2021)1645467
7-131504370-C-T PODXL-related disorder Likely benign (Dec 11, 2023)1528298
7-131504377-G-A Likely benign (Jan 20, 2023)2888177
7-131504381-T-C Likely benign (Apr 23, 2021)1553858
7-131504382-C-T Uncertain significance (Feb 24, 2022)1949928
7-131504383-C-A Benign (Jan 28, 2024)786111
7-131504411-T-A Inborn genetic diseases Uncertain significance (Nov 18, 2022)2358375
7-131504412-T-C Inborn genetic diseases Uncertain significance (Nov 18, 2022)2358374
7-131504415-TCTC-T Likely benign (Aug 06, 2022)2197484
7-131504424-T-C Inborn genetic diseases Uncertain significance (Feb 10, 2022)1905888
7-131504428-A-C Likely benign (Mar 28, 2018)735652
7-131504431-A-G Likely benign (Jun 14, 2021)1546903
7-131504449-C-T PODXL-related disorder Benign/Likely benign (Jan 18, 2024)790357
7-131504451-G-T Uncertain significance (Oct 17, 2022)1936195
7-131504464-A-G Likely benign (Aug 20, 2023)2982218
7-131504482-T-C Benign (Mar 27, 2023)770565
7-131504504-C-T Inborn genetic diseases Uncertain significance (Jul 14, 2023)2595685
7-131504505-G-A Uncertain significance (Oct 03, 2023)2698532

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PODXLprotein_codingprotein_codingENST00000378555 957956
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.001030.9971257380101257480.0000398
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6722713040.8910.00001693541
Missense in Polyphen6582.4870.788011003
Synonymous0.1211351370.9870.000008921196
Loss of Function2.69922.90.3940.00000135247

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001520.000152
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00004620.0000462
European (Non-Finnish)0.00004430.0000439
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in the regulation of both adhesion and cell morphology and cancer progression. Function as an anti-adhesive molecule that maintains an open filtration pathway between neighboring foot processes in the podocyte by charge repulsion. Acts as a pro-adhesive molecule, enhancing the adherence of cells to immobilized ligands, increasing the rate of migration and cell- cell contacts in an integrin-dependent manner. Induces the formation of apical actin-dependent microvilli. Involved in the formation of a preapical plasma membrane subdomain to set up initial epithelial polarization and the apical lumen formation during renal tubulogenesis. Plays a role in cancer development and aggressiveness by inducing cell migration and invasion through its interaction with the actin-binding protein EZR. Affects EZR- dependent signaling events, leading to increased activities of the MAPK and PI3K pathways in cancer cells. {ECO:0000269|PubMed:17616675, ECO:0000269|PubMed:18456258}.;
Pathway
miR-targeted genes in epithelium - TarBase;miR-targeted genes in muscle cell - TarBase;miR-targeted genes in squamous cell - TarBase;Primary Focal Segmental Glomerulosclerosis FSGS;Ectoderm Differentiation;Hepatitis C and Hepatocellular Carcinoma (Consensus)

Recessive Scores

pRec
0.0901

Intolerance Scores

loftool
0.580
rvis_EVS
1.38
rvis_percentile_EVS
94.6

Haploinsufficiency Scores

pHI
0.263
hipred
N
hipred_score
0.372
ghis
0.414

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.450

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Podxl
Phenotype
cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); respiratory system phenotype;

Zebrafish Information Network

Gene name
podxl
Affected structure
pronephric glomerular capsule
Phenotype tag
abnormal
Phenotype quality
cystic

Gene ontology

Biological process
cell adhesion;negative regulation of cell adhesion;cell migration;negative regulation of cell-cell adhesion;positive regulation of cell migration;regulation of microvillus assembly;positive regulation of cell-cell adhesion mediated by integrin;glomerular visceral epithelial cell development;epithelial tube formation
Cellular component
ruffle;extracellular space;nucleolus;cytoplasm;microtubule organizing center;plasma membrane;integral component of plasma membrane;apical plasma membrane;lamellipodium;filopodium;microvillus membrane;slit diaphragm;intracellular membrane-bounded organelle;membrane raft;extracellular exosome
Molecular function
protein binding